{
    "nctId": "NCT00808522",
    "briefTitle": "Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women",
    "officialTitle": "Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women.",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 84,
    "primaryOutcomeMeasure": "The investigators will be looking at the mammographic breast density at the start of the trial and then every 6 months for 2 years. The treatment arm will have 30 injections of Hcg over a 60 day period.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* On tamoxifen therapy for the treatment or prevention of breast cancer.\n* Must have at least one remaining breast.\n\nExclusion Criteria:\n\n* Pregnant or nursing.\n* No history of allergic reactions to hCG.\n* Patients who have had bilateral mastectomies.\n* Uncontrolled thyroid disease.\n* Cognitively impaired and unable to consent for the trial.",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}